A2 milk,
does it really help with Reduced acute gastrointestinal symptoms in adults who report discomfort after ordinary milk?
research showsThe grade is C with 52 points. In a double-blind crossover trial, 642 Chinese adults with self-reported milk intolerance started and 600 were analyzed. All six gastrointestinal symptom scores at one and three hours were lower after 300 mL A2 milk than after conventional A1/A2 milk. The study used one exposure, was fully funded by the a2 Milk Company, and was registered after completion, so everyday long-term benefit is not established.
ads claimThe difference is beta-casein type, not lactose. Trial lactose content was 5.0 g/100 mL in A2 milk and 4.8 g/100 mL in conventional milk. Verdict 037 is C with 55 points and concerns Lactium for sleep and stress; verdict 859 is ? with no score and concerns goat-milk protein and muscle, so neither duplicates whole A2 milk and acute digestive symptoms.
Useful facts when choosing a product
- Per 100 mL, A2 and conventional trial milks contained 5.0 and 4.8 g lactose and 117 and 120 mg calcium. A 300 mL serving therefore supplied about 15.0 and 14.4 g lactose.
- A2 milk contained only A2 beta-casein; conventional milk had an A1:A2 ratio near 58:42. This was not a lactose-free comparison.
- Saturated fat was 2.4 g versus 2.1 g per 100 mL, so the products were not compositionally identical in every respect.
- Epidemiologic synthesis reports lactose malabsorption as extremely common in Korean and Han Chinese populations. This indicates low adult lactase persistence at the population level, not symptoms in every individual.
What the research actually shows
Three centers screened 1,200 people, 642 began, and 42 who discontinued or lacked questionnaires were excluded, leaving 600, 200 per site. Participants consumed 300 mL A2 milk and 300 mL conventional milk with an A1:A2 ratio of 58:42, separated by seven days. NCT02878876 was registered on August 16, 2016 after study completion. The a2 Milk Company fully funded the study and medical writing, and all authors disclosed company honoraria. No coauthor was listed with a company affiliation.
Why this is classified as C (52)
The registered symptom endpoint was consistently positive with conventionally large magnitude, but the single-dose evidence was fully manufacturer funded and retrospectively registered, giving C with 52 points.
Counterpoint. C does not deny the acute difference; persistence with daily use and independent replication remain unresolved.
Rejudgment record. Cross-check applied — Trial-product composition, analysis count, registered three-hour endpoint, registration timing, funding, and conflicts were checked directly in the original paper and registry
| Endpoint | P | Patient-reported treatment goal - the symptom is the goal |
| Replication | R1 | Single confirmatory trial |
| Independence | I0 | Evidence comes only from manufacturer studies |
| Effect size | E+ | Meets the clinically important threshold |
The scoring table and the verdict agree (C).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| A 300 mL serving of A2 milk reduces one-to-three-hour digestive symptoms versus conventional milk | C | All six symptoms favored A2 milk in 600 participants, but evidence is one manufacturer-funded single-dose trial. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Study 1 | Multicenter randomized double-blind two-period crossover trial | 600 | Fully funded by the a2 Milk Company, including medical writing; all authors disclosed company honoraria | Six gastrointestinal symptom VAS scores three hours after 300 mL | All six P<0.0001; approximate r about 0.76 to 0.84 from GEE coefficients, standard errors, and N=600 | Large direct symptom trial limited by single exposure, manufacturer-only evidence, and retrospective registration |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-08-03).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-03 · Corrections: none
Cite this verdict
[Chamgap] A2 milk x reduced gastrointestinal symptoms after milk — Evidence Grade C·52. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/gut/a2-milk-acute-gastrointestinal-symptoms/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.